Targeting the disrupted Hippo signaling to prevent neoplastic renal epithelial cell immune evasion
Abstract Large-scale cancer genetic/genomic studies demonstrated that papillary renal cell carcinoma (pRCC) is featured with a frequent shallow deletion of the upstream tumor suppressors of the Hippo/YAP signaling pathway, suggesting that this signaling pathway may play a role in pRCC development. H...
Saved in:
| Main Authors: | Xiangmin Lv, Jiyuan Liu, Jinpeng Ruan, Peichao Chen, Chunbo He, Xingeng Zhao, Cong Huang, Li Chen, Hongbo Wang, Guohua Hua, Davie Shi, Siyi Yang, Madelyn L. Moness, Isabelle Montoute, Anjali Dhar, Xingcheng Chen, Raj Kumar, Lu Hu, Ruslan Sadreyev, Oladapo Yeku, Xu Wu, John S. Davis, Cheng Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-57697-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Author Correction: Targeting the disrupted Hippo signaling to prevent neoplastic renal epithelial cell immune evasion
by: Xiangmin Lv, et al.
Published: (2025-06-01) -
Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events
by: Li Chen, et al.
Published: (2025-01-01) -
The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression
by: Chunbo He, et al.
Published: (2015-09-01) -
ANO1: central role and clinical significance in non-neoplastic and neoplastic diseases
by: Yanghao Hu, et al.
Published: (2025-04-01) -
Hippo/YAP signaling’s multifaceted crosstalk in cancer
by: Jie Zhang, et al.
Published: (2025-07-01)